nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—ABCB1—esophageal cancer	0.355	1	CbGaD
Erythromycin—SLC22A7—Methotrexate—esophageal cancer	0.114	0.283	CbGbCtD
Erythromycin—ABCC1—Methotrexate—esophageal cancer	0.0896	0.222	CbGbCtD
Erythromycin—SLCO1A2—Methotrexate—esophageal cancer	0.08	0.198	CbGbCtD
Erythromycin—CYP2B6—Cisplatin—esophageal cancer	0.065	0.161	CbGbCtD
Erythromycin—ABCB1—Cisplatin—esophageal cancer	0.0333	0.0825	CbGbCtD
Erythromycin—ABCB1—Methotrexate—esophageal cancer	0.0216	0.0536	CbGbCtD
Erythromycin—MLNR—smooth muscle tissue—esophageal cancer	0.014	0.355	CbGeAlD
Erythromycin—MLNR—digestive system—esophageal cancer	0.011	0.28	CbGeAlD
Erythromycin—Superinfection—Capecitabine—esophageal cancer	0.00318	0.0753	CcSEcCtD
Erythromycin—Localized exfoliation—Capecitabine—esophageal cancer	0.00268	0.0635	CcSEcCtD
Erythromycin—Azithromycin—CYP2A6—esophageal cancer	0.00212	0.324	CrCbGaD
Erythromycin—SLC22A7—digestive system—esophageal cancer	0.00182	0.0462	CbGeAlD
Erythromycin—Troleandomycin—CYP2A6—esophageal cancer	0.00163	0.249	CrCbGaD
Erythromycin—Hepatotoxicity—Cisplatin—esophageal cancer	0.00127	0.03	CcSEcCtD
Erythromycin—ABCC1—bronchus—esophageal cancer	0.00117	0.0297	CbGeAlD
Erythromycin—Tenderness—Cisplatin—esophageal cancer	0.00112	0.0266	CcSEcCtD
Erythromycin—SLCO1A2—digestive system—esophageal cancer	0.0011	0.0279	CbGeAlD
Erythromycin—ABCC1—trachea—esophageal cancer	0.00105	0.0266	CbGeAlD
Erythromycin—Torsade de pointes—Capecitabine—esophageal cancer	0.00103	0.0244	CcSEcCtD
Erythromycin—Hearing impaired—Cisplatin—esophageal cancer	0.00103	0.0244	CcSEcCtD
Erythromycin—Pain—Carboplatin—esophageal cancer	0.00102	0.0241	CcSEcCtD
Erythromycin—Skin exfoliation—Cisplatin—esophageal cancer	0.000935	0.0221	CcSEcCtD
Erythromycin—Hepatotoxicity—Capecitabine—esophageal cancer	0.000935	0.0221	CcSEcCtD
Erythromycin—SLCO1A2—lung—esophageal cancer	0.00092	0.0233	CbGeAlD
Erythromycin—CYP2B6—bronchus—esophageal cancer	0.000894	0.0227	CbGeAlD
Erythromycin—Eruption—Methotrexate—esophageal cancer	0.000874	0.0207	CcSEcCtD
Erythromycin—Eye irritation—Capecitabine—esophageal cancer	0.000845	0.02	CcSEcCtD
Erythromycin—Deafness—Cisplatin—esophageal cancer	0.000795	0.0188	CcSEcCtD
Erythromycin—Azithromycin—ABCB1—esophageal cancer	0.000789	0.121	CrCbGaD
Erythromycin—Roxithromycin—ABCB1—esophageal cancer	0.000789	0.121	CrCbGaD
Erythromycin—Burning sensation—Methotrexate—esophageal cancer	0.000773	0.0183	CcSEcCtD
Erythromycin—Hearing impaired—Capecitabine—esophageal cancer	0.000758	0.018	CcSEcCtD
Erythromycin—ABCC1—lung—esophageal cancer	0.000755	0.0191	CbGeAlD
Erythromycin—CYP1A2—digestive system—esophageal cancer	0.00072	0.0183	CbGeAlD
Erythromycin—Hepatotoxicity—Methotrexate—esophageal cancer	0.000696	0.0165	CcSEcCtD
Erythromycin—CYP3A5—digestive system—esophageal cancer	0.000695	0.0176	CbGeAlD
Erythromycin—CYP2B6—digestive system—esophageal cancer	0.00069	0.0175	CbGeAlD
Erythromycin—Skin exfoliation—Capecitabine—esophageal cancer	0.000689	0.0163	CcSEcCtD
Erythromycin—Irritability—Cisplatin—esophageal cancer	0.000678	0.0161	CcSEcCtD
Erythromycin—Troleandomycin—ABCB1—esophageal cancer	0.000606	0.0929	CrCbGaD
Erythromycin—Pancreatitis—Cisplatin—esophageal cancer	0.000602	0.0143	CcSEcCtD
Erythromycin—CYP1A2—lung—esophageal cancer	0.000601	0.0153	CbGeAlD
Erythromycin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.0006	0.0142	CcSEcCtD
Erythromycin—Clarithromycin—ABCB1—esophageal cancer	0.000598	0.0915	CrCbGaD
Erythromycin—Abdominal discomfort—Cisplatin—esophageal cancer	0.000589	0.014	CcSEcCtD
Erythromycin—Deafness—Capecitabine—esophageal cancer	0.000586	0.0139	CcSEcCtD
Erythromycin—CYP3A5—lung—esophageal cancer	0.00058	0.0147	CbGeAlD
Erythromycin—CYP2B6—lung—esophageal cancer	0.000577	0.0146	CbGeAlD
Erythromycin—CYP3A4—digestive system—esophageal cancer	0.000521	0.0132	CbGeAlD
Erythromycin—ABCC1—lymph node—esophageal cancer	0.000516	0.0131	CbGeAlD
Erythromycin—Skin exfoliation—Methotrexate—esophageal cancer	0.000513	0.0122	CcSEcCtD
Erythromycin—Irritability—Capecitabine—esophageal cancer	0.0005	0.0118	CcSEcCtD
Erythromycin—ABCB1—epithelium—esophageal cancer	0.000485	0.0123	CbGeAlD
Erythromycin—Liver function test abnormal—Capecitabine—esophageal cancer	0.000484	0.0115	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000472	0.0112	CcSEcCtD
Erythromycin—Tinnitus—Cisplatin—esophageal cancer	0.000459	0.0109	CcSEcCtD
Erythromycin—Arrhythmia—Cisplatin—esophageal cancer	0.000439	0.0104	CcSEcCtD
Erythromycin—Abdominal discomfort—Capecitabine—esophageal cancer	0.000434	0.0103	CcSEcCtD
Erythromycin—ABCB1—trachea—esophageal cancer	0.000429	0.0109	CbGeAlD
Erythromycin—Erythema—Cisplatin—esophageal cancer	0.000428	0.0101	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.0004	0.00948	CcSEcCtD
Erythromycin—Jaundice—Capecitabine—esophageal cancer	0.000394	0.00932	CcSEcCtD
Erythromycin—Irritability—Methotrexate—esophageal cancer	0.000372	0.00882	CcSEcCtD
Erythromycin—Convulsion—Cisplatin—esophageal cancer	0.000371	0.00879	CcSEcCtD
Erythromycin—ABCB1—digestive system—esophageal cancer	0.000369	0.00936	CbGeAlD
Erythromycin—Hepatitis—Capecitabine—esophageal cancer	0.000363	0.00859	CcSEcCtD
Erythromycin—Liver function test abnormal—Methotrexate—esophageal cancer	0.00036	0.00853	CcSEcCtD
Erythromycin—Discomfort—Cisplatin—esophageal cancer	0.00036	0.00853	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000351	0.00832	CcSEcCtD
Erythromycin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000349	0.00828	CcSEcCtD
Erythromycin—Erythema multiforme—Capecitabine—esophageal cancer	0.000343	0.00812	CcSEcCtD
Erythromycin—Tinnitus—Capecitabine—esophageal cancer	0.000338	0.00801	CcSEcCtD
Erythromycin—Anorexia—Cisplatin—esophageal cancer	0.000333	0.00789	CcSEcCtD
Erythromycin—Pancreatitis—Methotrexate—esophageal cancer	0.000331	0.00783	CcSEcCtD
Erythromycin—Arrhythmia—Capecitabine—esophageal cancer	0.000324	0.00767	CcSEcCtD
Erythromycin—Abdominal discomfort—Methotrexate—esophageal cancer	0.000323	0.00766	CcSEcCtD
Erythromycin—Erythema—Capecitabine—esophageal cancer	0.000316	0.00747	CcSEcCtD
Erythromycin—Dysgeusia—Capecitabine—esophageal cancer	0.000309	0.00732	CcSEcCtD
Erythromycin—ABCB1—lung—esophageal cancer	0.000308	0.00782	CbGeAlD
Erythromycin—Decreased appetite—Cisplatin—esophageal cancer	0.000304	0.00719	CcSEcCtD
Erythromycin—Pain—Cisplatin—esophageal cancer	0.000299	0.00708	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000298	0.00706	CcSEcCtD
Erythromycin—Feeling abnormal—Cisplatin—esophageal cancer	0.000288	0.00682	CcSEcCtD
Erythromycin—Vertigo—Capecitabine—esophageal cancer	0.000284	0.00672	CcSEcCtD
Erythromycin—Palpitations—Capecitabine—esophageal cancer	0.000279	0.00661	CcSEcCtD
Erythromycin—Hepatitis—Methotrexate—esophageal cancer	0.00027	0.00639	CcSEcCtD
Erythromycin—Chest pain—Capecitabine—esophageal cancer	0.000269	0.00636	CcSEcCtD
Erythromycin—Discomfort—Capecitabine—esophageal cancer	0.000265	0.00629	CcSEcCtD
Erythromycin—Confusional state—Capecitabine—esophageal cancer	0.00026	0.00615	CcSEcCtD
Erythromycin—Hypersensitivity—Cisplatin—esophageal cancer	0.000257	0.0061	CcSEcCtD
Erythromycin—Erythema multiforme—Methotrexate—esophageal cancer	0.000255	0.00604	CcSEcCtD
Erythromycin—Tinnitus—Methotrexate—esophageal cancer	0.000252	0.00596	CcSEcCtD
Erythromycin—Anorexia—Capecitabine—esophageal cancer	0.000245	0.00581	CcSEcCtD
Erythromycin—Diarrhoea—Cisplatin—esophageal cancer	0.000239	0.00566	CcSEcCtD
Erythromycin—Erythema—Methotrexate—esophageal cancer	0.000235	0.00556	CcSEcCtD
Erythromycin—Dysgeusia—Methotrexate—esophageal cancer	0.00023	0.00545	CcSEcCtD
Erythromycin—Decreased appetite—Capecitabine—esophageal cancer	0.000224	0.0053	CcSEcCtD
Erythromycin—Vomiting—Cisplatin—esophageal cancer	0.000222	0.00526	CcSEcCtD
Erythromycin—Rash—Cisplatin—esophageal cancer	0.00022	0.00522	CcSEcCtD
Erythromycin—Pain—Capecitabine—esophageal cancer	0.00022	0.00522	CcSEcCtD
Erythromycin—Feeling abnormal—Capecitabine—esophageal cancer	0.000212	0.00503	CcSEcCtD
Erythromycin—Vertigo—Methotrexate—esophageal cancer	0.000211	0.005	CcSEcCtD
Erythromycin—ABCB1—lymph node—esophageal cancer	0.000211	0.00535	CbGeAlD
Erythromycin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000211	0.00499	CcSEcCtD
Erythromycin—Nausea—Cisplatin—esophageal cancer	0.000208	0.00492	CcSEcCtD
Erythromycin—Urticaria—Capecitabine—esophageal cancer	0.000205	0.00485	CcSEcCtD
Erythromycin—Abdominal pain—Capecitabine—esophageal cancer	0.000204	0.00482	CcSEcCtD
Erythromycin—Convulsion—Methotrexate—esophageal cancer	0.000204	0.00482	CcSEcCtD
Erythromycin—Chest pain—Methotrexate—esophageal cancer	0.0002	0.00474	CcSEcCtD
Erythromycin—Discomfort—Methotrexate—esophageal cancer	0.000198	0.00468	CcSEcCtD
Erythromycin—Confusional state—Methotrexate—esophageal cancer	0.000193	0.00458	CcSEcCtD
Erythromycin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000192	0.00454	CcSEcCtD
Erythromycin—Hypersensitivity—Capecitabine—esophageal cancer	0.00019	0.00449	CcSEcCtD
Erythromycin—Anorexia—Methotrexate—esophageal cancer	0.000183	0.00433	CcSEcCtD
Erythromycin—Pruritus—Capecitabine—esophageal cancer	0.000182	0.00432	CcSEcCtD
Erythromycin—Diarrhoea—Capecitabine—esophageal cancer	0.000176	0.00417	CcSEcCtD
Erythromycin—Dizziness—Capecitabine—esophageal cancer	0.00017	0.00403	CcSEcCtD
Erythromycin—Decreased appetite—Methotrexate—esophageal cancer	0.000167	0.00395	CcSEcCtD
Erythromycin—Pain—Methotrexate—esophageal cancer	0.000164	0.00388	CcSEcCtD
Erythromycin—Vomiting—Capecitabine—esophageal cancer	0.000164	0.00388	CcSEcCtD
Erythromycin—Rash—Capecitabine—esophageal cancer	0.000162	0.00385	CcSEcCtD
Erythromycin—Feeling abnormal—Methotrexate—esophageal cancer	0.000158	0.00374	CcSEcCtD
Erythromycin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000157	0.00371	CcSEcCtD
Erythromycin—Nausea—Capecitabine—esophageal cancer	0.000153	0.00362	CcSEcCtD
Erythromycin—Urticaria—Methotrexate—esophageal cancer	0.000152	0.00361	CcSEcCtD
Erythromycin—Abdominal pain—Methotrexate—esophageal cancer	0.000152	0.00359	CcSEcCtD
Erythromycin—Hypersensitivity—Methotrexate—esophageal cancer	0.000141	0.00335	CcSEcCtD
Erythromycin—Pruritus—Methotrexate—esophageal cancer	0.000136	0.00321	CcSEcCtD
Erythromycin—Diarrhoea—Methotrexate—esophageal cancer	0.000131	0.00311	CcSEcCtD
Erythromycin—Dizziness—Methotrexate—esophageal cancer	0.000127	0.003	CcSEcCtD
Erythromycin—Vomiting—Methotrexate—esophageal cancer	0.000122	0.00289	CcSEcCtD
Erythromycin—Rash—Methotrexate—esophageal cancer	0.000121	0.00286	CcSEcCtD
Erythromycin—Nausea—Methotrexate—esophageal cancer	0.000114	0.0027	CcSEcCtD
Erythromycin—SLCO1A2—Metabolism—CYP2A6—esophageal cancer	4.29e-05	0.000281	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ADH7—esophageal cancer	4.29e-05	0.000281	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PLCE1—esophageal cancer	4.29e-05	0.000281	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.28e-05	0.00028	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ALDOB—esophageal cancer	4.21e-05	0.000276	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ADH7—esophageal cancer	4.19e-05	0.000274	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PLCE1—esophageal cancer	4.19e-05	0.000274	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CALR—esophageal cancer	4.13e-05	0.00027	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ALDH2—esophageal cancer	4.11e-05	0.000269	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ENO1—esophageal cancer	4.07e-05	0.000266	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PTGS1—esophageal cancer	4.07e-05	0.000266	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.07e-05	0.000266	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GAPDH—esophageal cancer	4.06e-05	0.000265	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CRABP1—esophageal cancer	4.02e-05	0.000263	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PSME2—esophageal cancer	4.01e-05	0.000262	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PSME1—esophageal cancer	4.01e-05	0.000262	CbGpPWpGaD
Erythromycin—ABCC1—Disease—FBXW7—esophageal cancer	4e-05	0.000262	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	3.93e-05	0.000257	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GSTT1—esophageal cancer	3.91e-05	0.000256	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CYP2A6—esophageal cancer	3.86e-05	0.000253	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.85e-05	0.000252	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GNG7—esophageal cancer	3.82e-05	0.00025	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	3.78e-05	0.000247	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ADH1B—esophageal cancer	3.76e-05	0.000246	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PIK3CA—esophageal cancer	3.75e-05	0.000245	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CA1—esophageal cancer	3.72e-05	0.000243	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—SLC10A2—esophageal cancer	3.72e-05	0.000243	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ADH1B—esophageal cancer	3.68e-05	0.00024	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	3.67e-05	0.00024	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ENO1—esophageal cancer	3.66e-05	0.00024	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PTGS1—esophageal cancer	3.66e-05	0.00024	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.66e-05	0.000239	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TP53—esophageal cancer	3.62e-05	0.000237	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PSME1—esophageal cancer	3.61e-05	0.000236	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PSME2—esophageal cancer	3.61e-05	0.000236	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—TYMP—esophageal cancer	3.59e-05	0.000235	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	3.59e-05	0.000235	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ALDH2—esophageal cancer	3.58e-05	0.000234	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—TYMP—esophageal cancer	3.51e-05	0.00023	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.5e-05	0.000229	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CYP26A1—esophageal cancer	3.5e-05	0.000229	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—BLVRB—esophageal cancer	3.49e-05	0.000229	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—SLC52A3—esophageal cancer	3.49e-05	0.000229	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CYP1B1—esophageal cancer	3.46e-05	0.000226	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CYP26A1—esophageal cancer	3.42e-05	0.000224	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GSTT1—esophageal cancer	3.41e-05	0.000223	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ALOX15—esophageal cancer	3.41e-05	0.000223	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CA2—esophageal cancer	3.4e-05	0.000223	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CYP2A6—esophageal cancer	3.37e-05	0.00022	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ALOX15—esophageal cancer	3.33e-05	0.000218	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CYP19A1—esophageal cancer	3.25e-05	0.000213	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GSTO1—esophageal cancer	3.25e-05	0.000213	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—TPI1—esophageal cancer	3.25e-05	0.000213	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.24e-05	0.000212	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TGFBR2—esophageal cancer	3.23e-05	0.000212	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PTGS1—esophageal cancer	3.19e-05	0.000209	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ENO1—esophageal cancer	3.19e-05	0.000209	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GSTO1—esophageal cancer	3.18e-05	0.000208	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—TPI1—esophageal cancer	3.18e-05	0.000208	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ADH7—esophageal cancer	3.16e-05	0.000207	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PLCE1—esophageal cancer	3.16e-05	0.000207	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.15e-05	0.000206	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PSME2—esophageal cancer	3.15e-05	0.000206	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PSME1—esophageal cancer	3.15e-05	0.000206	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.14e-05	0.000205	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.12e-05	0.000204	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ALDOB—esophageal cancer	3.12e-05	0.000204	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CYP1B1—esophageal cancer	3.11e-05	0.000204	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SMAD4—esophageal cancer	3.06e-05	0.0002	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ALDOB—esophageal cancer	3.05e-05	0.000199	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GAPDH—esophageal cancer	3e-05	0.000196	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.99e-05	0.000195	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CRABP1—esophageal cancer	2.97e-05	0.000194	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—SLC10A2—esophageal cancer	2.97e-05	0.000194	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CA1—esophageal cancer	2.97e-05	0.000194	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—HMOX1—esophageal cancer	2.97e-05	0.000194	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GAPDH—esophageal cancer	2.93e-05	0.000192	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CYP19A1—esophageal cancer	2.93e-05	0.000192	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.91e-05	0.000191	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CRABP1—esophageal cancer	2.91e-05	0.00019	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ABCB1—esophageal cancer	2.85e-05	0.000186	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GNG7—esophageal cancer	2.83e-05	0.000185	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ADH1B—esophageal cancer	2.77e-05	0.000181	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GNG7—esophageal cancer	2.76e-05	0.000181	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CA2—esophageal cancer	2.72e-05	0.000178	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CYP1B1—esophageal cancer	2.72e-05	0.000178	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.71e-05	0.000178	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.7e-05	0.000176	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.7e-05	0.000176	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—HMOX1—esophageal cancer	2.67e-05	0.000175	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.65e-05	0.000174	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—TYMP—esophageal cancer	2.65e-05	0.000173	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ALDH2—esophageal cancer	2.65e-05	0.000173	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.62e-05	0.000171	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.6e-05	0.00017	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ALDH2—esophageal cancer	2.59e-05	0.000169	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.58e-05	0.000169	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ABCB1—esophageal cancer	2.56e-05	0.000168	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CYP19A1—esophageal cancer	2.55e-05	0.000167	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.54e-05	0.000166	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ADH7—esophageal cancer	2.53e-05	0.000165	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PLCE1—esophageal cancer	2.53e-05	0.000165	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GSTT1—esophageal cancer	2.52e-05	0.000165	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ALOX15—esophageal cancer	2.51e-05	0.000164	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HIF1A—esophageal cancer	2.5e-05	0.000164	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.5e-05	0.000163	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CYP2A6—esophageal cancer	2.49e-05	0.000163	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GSTT1—esophageal cancer	2.46e-05	0.000161	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CYP2A6—esophageal cancer	2.43e-05	0.000159	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GSTO1—esophageal cancer	2.4e-05	0.000157	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—TPI1—esophageal cancer	2.4e-05	0.000157	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ENO1—esophageal cancer	2.36e-05	0.000155	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PTGS1—esophageal cancer	2.36e-05	0.000155	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—HMOX1—esophageal cancer	2.33e-05	0.000152	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PSME2—esophageal cancer	2.33e-05	0.000152	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PSME1—esophageal cancer	2.33e-05	0.000152	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ENO1—esophageal cancer	2.31e-05	0.000151	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PTGS1—esophageal cancer	2.31e-05	0.000151	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ALDOB—esophageal cancer	2.3e-05	0.00015	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.29e-05	0.00015	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CA1—esophageal cancer	2.29e-05	0.00015	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NOS2—esophageal cancer	2.28e-05	0.000149	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PSME2—esophageal cancer	2.27e-05	0.000149	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PSME1—esophageal cancer	2.27e-05	0.000149	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NOTCH1—esophageal cancer	2.26e-05	0.000148	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ABCB1—esophageal cancer	2.24e-05	0.000146	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ADH1B—esophageal cancer	2.21e-05	0.000145	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GAPDH—esophageal cancer	2.21e-05	0.000145	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.21e-05	0.000144	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CRABP1—esophageal cancer	2.19e-05	0.000143	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.15e-05	0.000141	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.14e-05	0.00014	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—TYMP—esophageal cancer	2.12e-05	0.000138	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CA2—esophageal cancer	2.1e-05	0.000137	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GNG7—esophageal cancer	2.09e-05	0.000136	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CYP26A1—esophageal cancer	2.06e-05	0.000135	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CREBBP—esophageal cancer	2.05e-05	0.000134	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CYP1B1—esophageal cancer	2.01e-05	0.000131	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ALOX15—esophageal cancer	2.01e-05	0.000131	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CYP1B1—esophageal cancer	1.96e-05	0.000128	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ALDH2—esophageal cancer	1.95e-05	0.000128	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.95e-05	0.000128	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ADH7—esophageal cancer	1.95e-05	0.000128	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.94e-05	0.000127	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.91e-05	0.000125	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—TPI1—esophageal cancer	1.91e-05	0.000125	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CREBBP—esophageal cancer	1.9e-05	0.000125	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CYP19A1—esophageal cancer	1.89e-05	0.000124	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GSTT1—esophageal cancer	1.86e-05	0.000122	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CYP19A1—esophageal cancer	1.85e-05	0.000121	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.84e-05	0.00012	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.83e-05	0.00012	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NOS3—esophageal cancer	1.83e-05	0.00012	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.77e-05	0.000116	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.75e-05	0.000115	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ENO1—esophageal cancer	1.74e-05	0.000114	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PTGS1—esophageal cancer	1.74e-05	0.000114	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.74e-05	0.000114	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—HMOX1—esophageal cancer	1.72e-05	0.000113	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PSME1—esophageal cancer	1.72e-05	0.000112	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PSME2—esophageal cancer	1.72e-05	0.000112	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CREBBP—esophageal cancer	1.71e-05	0.000112	CbGpPWpGaD
Erythromycin—ABCC1—Disease—ERBB2—esophageal cancer	1.71e-05	0.000112	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.71e-05	0.000112	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—NOS3—esophageal cancer	1.7e-05	0.000112	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—HMOX1—esophageal cancer	1.68e-05	0.00011	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PTGS2—esophageal cancer	1.68e-05	0.00011	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GNG7—esophageal cancer	1.66e-05	0.000109	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ABCB1—esophageal cancer	1.65e-05	0.000108	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—TYMP—esophageal cancer	1.63e-05	0.000107	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ABCB1—esophageal cancer	1.62e-05	0.000106	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.59e-05	0.000104	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.56e-05	0.000102	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PTGS2—esophageal cancer	1.56e-05	0.000102	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.55e-05	0.000101	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—NOS3—esophageal cancer	1.53e-05	0.0001	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CREBBP—esophageal cancer	1.49e-05	9.78e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.48e-05	9.71e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.48e-05	9.69e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.48e-05	9.66e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—TPI1—esophageal cancer	1.48e-05	9.66e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.47e-05	9.6e-05	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CDKN1A—esophageal cancer	1.46e-05	9.58e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.46e-05	9.56e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.42e-05	9.26e-05	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PTGS2—esophageal cancer	1.4e-05	9.18e-05	CbGpPWpGaD
Erythromycin—ABCC1—Disease—EP300—esophageal cancer	1.39e-05	9.12e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.39e-05	9.11e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.39e-05	9.1e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ENO1—esophageal cancer	1.39e-05	9.1e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PSME2—esophageal cancer	1.37e-05	8.96e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PSME1—esophageal cancer	1.37e-05	8.96e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.36e-05	8.92e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.35e-05	8.84e-05	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—NOS3—esophageal cancer	1.34e-05	8.75e-05	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—EP300—esophageal cancer	1.3e-05	8.48e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GNG7—esophageal cancer	1.28e-05	8.41e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—HMOX1—esophageal cancer	1.27e-05	8.31e-05	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PTGS2—esophageal cancer	1.22e-05	8.01e-05	CbGpPWpGaD
Erythromycin—ABCC1—Disease—MYC—esophageal cancer	1.21e-05	7.94e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.2e-05	7.88e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.2e-05	7.83e-05	CbGpPWpGaD
Erythromycin—ABCC1—Disease—EGFR—esophageal cancer	1.19e-05	7.77e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.18e-05	7.74e-05	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—EP300—esophageal cancer	1.17e-05	7.63e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.15e-05	7.49e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.13e-05	7.41e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.11e-05	7.27e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CREBBP—esophageal cancer	1.11e-05	7.23e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.08e-05	7.07e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.07e-05	7.02e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ENO1—esophageal cancer	1.07e-05	7.02e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PSME2—esophageal cancer	1.06e-05	6.92e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PSME1—esophageal cancer	1.06e-05	6.92e-05	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PIK3CA—esophageal cancer	1.03e-05	6.74e-05	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—EP300—esophageal cancer	1.02e-05	6.66e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.01e-05	6.64e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.95e-06	6.51e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—NOS3—esophageal cancer	9.89e-06	6.47e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ABCB1—esophageal cancer	9.74e-06	6.37e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—NOS3—esophageal cancer	9.67e-06	6.33e-05	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	9.59e-06	6.28e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.12e-06	5.97e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PTGS2—esophageal cancer	9.05e-06	5.92e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PTGS2—esophageal cancer	8.85e-06	5.79e-05	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PIK3CA—esophageal cancer	8.63e-06	5.65e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	8.58e-06	5.61e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CREBBP—esophageal cancer	8.15e-06	5.33e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—HMOX1—esophageal cancer	7.83e-06	5.12e-05	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PIK3CA—esophageal cancer	7.53e-06	4.93e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—EP300—esophageal cancer	7.53e-06	4.92e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.51e-06	4.92e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.36e-06	4.82e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—EP300—esophageal cancer	7.36e-06	4.81e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—NOS3—esophageal cancer	7.3e-06	4.77e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PTGS2—esophageal cancer	6.67e-06	4.37e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CREBBP—esophageal cancer	6.51e-06	4.26e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—NOS3—esophageal cancer	5.83e-06	3.81e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PIK3CA—esophageal cancer	5.57e-06	3.64e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—EP300—esophageal cancer	5.55e-06	3.63e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PIK3CA—esophageal cancer	5.44e-06	3.56e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PTGS2—esophageal cancer	5.33e-06	3.49e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.02e-06	3.29e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—NOS3—esophageal cancer	4.5e-06	2.94e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—EP300—esophageal cancer	4.43e-06	2.9e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.11e-06	2.69e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PIK3CA—esophageal cancer	4.11e-06	2.69e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—EP300—esophageal cancer	3.42e-06	2.24e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PIK3CA—esophageal cancer	3.28e-06	2.14e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.53e-06	1.66e-05	CbGpPWpGaD
